Table 5.
SCFA | Group | Baseline | Intake 1 | Intake 2 | Follow-up |
---|---|---|---|---|---|
Acetate | HS | 21.49 (24.20) | 29.37 (29.67)a | 22.94 (35.25)a | 14.25 (25.24) |
NS | 32.03 (28.18) | 18.70 (18.77)b | 27.12 (23.65) | 19.51 (28.78)a | |
SS | 44.54 (11.64)c | 29.61 (33.07) | 34.98 (20.07) | 21.73 (20.91)b | |
Total | 30.65 (29.84) | 24.32 (26.31) | 30.24 (24.96) | 18.24 (25.86)b | |
Propionate | HS | 12.30 (10.98) | 14.92 (10.49)b | 13.32 (8.33) | 10.93 (12.81) |
NS | 15.17 (13.37) | 13.91 (7.98) | 14.06 (13.22) | 13.63 (9.81)b | |
SS | 18.67 (18.94)c | 18.30 (16.69) | 19.46 (14.33) | 14.41 (8.59)b | |
Total | 15.42 (12.26) | 14.81 (9.21) | 14.15 (10.85) | 11.39 (10.04)b | |
Butyrate | HS | 8.37 (12.28) | 16.18 (9.06)b | 11.22 (12.91) | 9.73 (15.46) |
NS | 14.64 (10.60) | 13.53 (12.67) | 13.33 (14.10) | 10.15 (12.22) | |
SS | 17.41 (22.75)c | 14.43 (20.77) | 17.13 (15.02) | 9.73 (13.72)b | |
Total | 14.34 (12.33) | 14.43 (11.11) | 12.91 (13.89) | 9.97 (13.64) |
P < 0.1, vs baseline.
P < 0.05, vs baseline.
P < 0.05, vs HS.
HS, hard stool; NS, normal stool; SS, soft stool; intake 1, 2-week LcS intake; intake 2, 4-week LcS intake; follow-up, 2-week following LcS intake.
Data are presented as median (interquartile range).